Literature DB >> 27220617

Low-Affinity Neurotrophin Receptor p75 Promotes the Transduction of Targeted Lentiviral Vectors to Cholinergic Neurons of Rat Basal Forebrain.

Inga Antyborzec1, Valerie B O'Leary1,2, James O Dolly1, Saak V Ovsepian3,4,5.   

Abstract

Basal forebrain cholinergic neurons (BFCNs) are one of the most affected neuronal types in Alzheimer's disease (AD), with their extensive loss documented at late stages of the pathology. While discriminatory provision of neuroprotective agents and trophic factors to these cells is thought to be of substantial therapeutic potential, the intricate topography and structure of the forebrain cholinergic system imposes a major challenge. To overcome this, we took advantage of the physiological enrichment of BFCNs with a low-affinity p75 neurotrophin receptor (p75NTR) for their targeting by lentiviral vectors within the intact brain of adult rat. Herein, a method is described that affords selective and effective transduction of BFCNs with a green fluorescence protein (GFP) reporter, which combines streptavidin-biotin technology with anti-p75NTR antibody-coated lentiviral vectors. Specific GFP expression in cholinergic neurons was attained in the medial septum and nuclei of the diagonal band Broca after a single intraventricular administration of such targeted vectors. Bioelectrical activity of GFP-labeled neurons was proven to be unchanged. Thus, proof of principle is obtained for the utility of the low-affinity p75NTR for targeted transduction of vectors to BFCNs in vivo.

Entities:  

Keywords:  Alzheimer’s disease; Basal forebrain cholinergic neurons; Gene therapy; Neuroprotection; Streptavidin–biotin; p75 neurotrophin receptor

Mesh:

Substances:

Year:  2016        PMID: 27220617      PMCID: PMC5081123          DOI: 10.1007/s13311-016-0445-3

Source DB:  PubMed          Journal:  Neurotherapeutics        ISSN: 1878-7479            Impact factor:   7.620


  69 in total

Review 1.  Cholinergic system during the progression of Alzheimer's disease: therapeutic implications.

Authors:  Elliott J Mufson; Scott E Counts; Sylvia E Perez; Stephen D Ginsberg
Journal:  Expert Rev Neurother       Date:  2008-11       Impact factor: 4.618

2.  Immunolesioning: selective destruction of neurons using immunotoxin to rat NGF receptor.

Authors:  R G Wiley; T N Oeltmann; D A Lappi
Journal:  Brain Res       Date:  1991-10-18       Impact factor: 3.252

3.  Selective loss of central cholinergic neurons in Alzheimer's disease.

Authors:  P Davies; A J Maloney
Journal:  Lancet       Date:  1976-12-25       Impact factor: 79.321

4.  Alzheimer disease: evidence for selective loss of cholinergic neurons in the nucleus basalis.

Authors:  P J Whitehouse; D L Price; A W Clark; J T Coyle; M R DeLong
Journal:  Ann Neurol       Date:  1981-08       Impact factor: 10.422

Review 5.  Avidin-biotin technology in targeted therapy.

Authors:  Hanna P Lesch; Minna U Kaikkonen; Jere T Pikkarainen; Seppo Ylä-Herttuala
Journal:  Expert Opin Drug Deliv       Date:  2010-05       Impact factor: 6.648

6.  Effects of intraventricular transplantation of NGF-secreting cells on cholinergic basal forebrain neurons after partial immunolesion.

Authors:  S Rossner; J Yu; D Pizzo; K Werrbach-Perez; R Schliebs; V Bigl; J R Perez-Polo
Journal:  J Neurosci Res       Date:  1996-07-01       Impact factor: 4.164

7.  A versatile targeting system with lentiviral vectors bearing the biotin-adaptor peptide.

Authors:  Kouki Morizono; Yiming Xie; Gustavo Helguera; Tracy R Daniels; Timothy F Lane; Manuel L Penichet; Irvin S Y Chen
Journal:  J Gene Med       Date:  2009-08       Impact factor: 4.565

8.  Complete and selective cholinergic denervation of rat neocortex and hippocampus but not amygdala by an immunotoxin against the p75 NGF receptor.

Authors:  S Heckers; T Ohtake; R G Wiley; D A Lappi; C Geula; M M Mesulam
Journal:  J Neurosci       Date:  1994-03       Impact factor: 6.167

9.  TrkA expression in the CNS: evidence for the existence of several novel NGF-responsive CNS neurons.

Authors:  D M Holtzman; J Kilbridge; Y Li; E T Cunningham; N J Lenn; D O Clary; L F Reichardt; W C Mobley
Journal:  J Neurosci       Date:  1995-02       Impact factor: 6.167

10.  Rab5 and Rab7 control endocytic sorting along the axonal retrograde transport pathway.

Authors:  Katrin Deinhardt; Sara Salinas; Carole Verastegui; Rose Watson; Daniel Worth; Sarah Hanrahan; Cecilia Bucci; Giampietro Schiavo
Journal:  Neuron       Date:  2006-10-19       Impact factor: 17.173

View more
  2 in total

1.  Alleviation of Trigeminal Nociception Using p75 Neurotrophin Receptor Targeted Lentiviral Interference Therapy.

Authors:  Valerie B O'Leary; Marie O'Connell; Inga Antyborzec; Vasilis Ntziachristos; J Oliver Dolly; Saak V Ovsepian
Journal:  Neurotherapeutics       Date:  2018-04       Impact factor: 7.620

Review 2.  Integrated phylogeny of the human brain and pathobiology of Alzheimer's disease: A unifying hypothesis.

Authors:  Saak V Ovsepian; Valerie B O'Leary; Cyril Hoschl; Laszlo Zaborszky
Journal:  Neurosci Lett       Date:  2021-04-20       Impact factor: 3.197

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.